Skip to content

Safety and Efficacy of the LVIS and LVIS JR Devices in the Endovascular Treatment of Intracranial Aneurysms

A French, Multicenter, Prospective, Observational, Real Life Assessment of the Safety and Efficacy of the Low Profile Visualized Intraluminal Support (LVIS and LVIS JR) Devices in the Treatment of Intracranial Aneurysms

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03553771
Enrollment
130
Registered
2018-06-12
Start date
2018-02-07
Completion date
2021-07-01
Last updated
2024-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Aneurysm

Keywords

aneurysm, endovascular

Brief summary

A French, multicenter, prospective, observational, real life assessment of the safety and efficacy of LVIS and LVIS JR devices in the treatment of intracranial aneurysms

Detailed description

This is a multicenter observational study. Treatment and follow-up visits will be done as per standard of care. The purpose of this study is to collect data on safety of the devices used since the French reimbursement. 130 patients will be enrolled over an 18-month recruitment period. All patients will be followed for at least 12 months.

Interventions

DEVICELVIS and LVIS JR

Braided coil assist stents used for aneurysm embolization

Sponsors

Clinact
CollaboratorOTHER
Microvention-Terumo, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patient with an intracranial aneurysm for which an endovascular treatment is indicated with the device LVIS or LVIS JR, either scheduled or emergency ( Bail-out stenting ) * Patient or patient's legally authorized representative has been informed about the study and does not oppose the collection of his/her personal data

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Mortality Rate1 year
Morbidity Rate1 yearNumber of adverse events with clinical impact related to the procedure and/or the device

Secondary

MeasureTime frameDescription
Clinical effectiveness1 yearNumber of patients with mRS\>2
Anatomical effectiveness1 yearNumber of patients with complete occlusion of the treated aneurysm
Retreatment rate1 year

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026